GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: AMR-69 | Esbriet®
pirfenidone is an approved drug (EMA (2011), FDA (2014))
Compound class:
Synthetic organic
Comment: Pirfenidone is an anti-fibrotic drug. In addition to its proven anti-fibrotic effects in lung tissue, pirfenidone-induced in vitro and in vivo anti-fibrotic activity has been reported in experimental liver and renal fibrosis [3,5].
SARS-CoV-2: COVID-19 is accompanied by inflammation and fibrotic lung damage that appears to persist beyond immediate recovery. The clinical potential for applying the antifibrotic activity of pirfenidone to help treat COVID-19-related pulmonary fibrosis is reviewed by Ferrara et al. (2020) [2]. |
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. EU EMA (2011) | US FDA (2014) |
IUPAC Name ![]() |
| 5-methyl-1-phenylpyridin-2-one |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 3825 | pirfenidone |
Synonyms ![]() |
| AMR-69 | Esbriet® |
Database Links ![]() |
|
| Specialist databases | |
Reactome Drug
|
R-ALL-9683547 |
Reactome Reaction
|
R-HSA-9683546 |
| Other databases | |
| CAS Registry No. | 53179-13-8 |
| ChEMBL Ligand | CHEMBL1256391 |
| DrugBank Ligand | DB04951 |
| DrugCentral Ligand | 4224 |
| GtoPdb PubChem SID | 187051833 |
| PubChem CID | 40632 |
| Search Google for chemical match using the InChIKey | ISWRGOKTTBVCFA-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | ISWRGOKTTBVCFA |
| Search PubMed clinical trials | pirfenidone |
| Search PubMed titles | pirfenidone |
| Search PubMed titles/abstracts | pirfenidone |
| UniChem Compound Search for chemical match using the InChIKey | ISWRGOKTTBVCFA-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | ISWRGOKTTBVCFA-UHFFFAOYSA-N |
| Wikipedia | Pirfenidone |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
Pirfenidone (links to external site)
Cat. No. HY-B0673 |